CN Patent

CN114375193B — 甲状腺激素受体β激动剂化合物

Assigned to Tuozhen Pharmaceutical Co · Expires 2024-05-14 · 2y expired

What this patent protects

本文提供了化合物，优选甲状腺激素受体β(THRβ)激动剂化合物、其组合物和其制备方法，及使THRβ激动的方法以及治疗THRβ所介导的病症的方法。

USPTO Abstract

本文提供了化合物，优选甲状腺激素受体β(THRβ)激动剂化合物、其组合物和其制备方法，及使THRβ激动的方法以及治疗THRβ所介导的病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114375193B
Jurisdiction
CN
Classification
—
Expires
2024-05-14
Drug substance claim
No
Drug product claim
No
Assignee
Tuozhen Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.